Type 2 diabetes specialist care in Italy in the AMD Annals initiative 2024: The path is traced
Authors' conclusion
The 2024 data confirm ongoing improvements in T2D care, despite an aging population. Although gaps persist, the path toward aligning practice with guidelines is well established.
Study context
- Population
- Patients with T2D attending Italian diabetes centers (AMD Annals initiative 2024); 58.6 % men, mean age 69.9 years, 35.9 % > 75 years
- Participants
- 680,122 patients301 centers
- Outcome
- Quality-of-care indicators in T2D, 2024
- Follow-up
- 2024
Methodological detailsmulticentre, anonymized electronic medical records, standardized quality indicators
- Multicentre
- Anonymized electronic medical records
- Standardized quality indicators
Main finding
As reported in the abstract
- HbA1c ≤ 7.0 % achieved
- 55.9 %
- LDL < 70 mg/dl achieved
- 44.6 %
- Blood pressure (BP) < 130/80 mmHg achieved
- 26.5 %
- Meeting multiple targets
- 7.7 %
- Obesity prevalence
- 35 %
- Smoking
- 17.9 %
- Lipid-lowering drugs
- 72.0 %
- BP-lowering drugs
- 68.8 %
- Glucose-lowering drugs
- 97.6 %
- SGLT2i (increasing trend vs 2023)
- 41.9 %
- GLP-1 RA (increasing trend vs 2023)
- 35.5 %
Observational data: associations, not effects.
Original publication
Type 2 diabetes specialist care in Italy in the AMD Annals initiative 2024: The path is traced. Diabetes Res Clin Pract. Published 21 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →